Barclays Maintains an 'Equalweight' on Host Hotels (HST); Adjusts Estimates After Asset Sale & Refi
Get Alerts HST Hot Sheet
Price: $22.92 --0%
Rating Summary:
17 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 6 | New: 10
Rating Summary:
17 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 6 | New: 10
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Host Hotels (NYSE: HST) price target of $17.00.
Analyst, Sule Sauvigne, said, "We are fine-tuning our estimates for Host following a non-core asset sale and several debt refinancing transactions...Our 2012 FFO/sh estimate goes to $1.03 from $1.02 and adj. EBITDA goes to $1,125mn from $1,135mn. Our 2013 FFO/sh estimate goes to $1.29 from $1.28 and adj. EBITDA goes to $1,296mn from $1,307mn."
For an analyst ratings summary and ratings history on Host Hotels click here. For more ratings news on Host Hotels click here.
Shares of Host Hotels closed at $16.17 yesterday.
Analyst, Sule Sauvigne, said, "We are fine-tuning our estimates for Host following a non-core asset sale and several debt refinancing transactions...Our 2012 FFO/sh estimate goes to $1.03 from $1.02 and adj. EBITDA goes to $1,125mn from $1,135mn. Our 2013 FFO/sh estimate goes to $1.29 from $1.28 and adj. EBITDA goes to $1,296mn from $1,307mn."
For an analyst ratings summary and ratings history on Host Hotels click here. For more ratings news on Host Hotels click here.
Shares of Host Hotels closed at $16.17 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BHP (BHP:LN) (BHP) PT Raised to GBP28.25 at Barclays
- BMO Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Outperform
- BMO Capital Starts Bicara Therapeutics Inc (BCAX) at Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share